Association of serum IGF1 with endothelial function: Results from the population-based study of health in Pomerania

European Journal of Endocrinology

Volumn 163, Issue 4, 2010, Pages 617-623

  Empen, Klaus ^a   Lorbeer, Roberto ^a   Völzke, Henry ^a   Robinson, Daniel M ^a   Friedrich, Nele ^a   Krebs, Alexander ^a   Nauck, Matthias ^a   Reffelmann, Thorsten ^a   Ewert, Ralf ^a   Felix, Stephan B ^a   Wallaschofski, Henri ^a   Dörr, Marcus ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; IGFBP3 PROTEIN, HUMAN; SOMATOMEDIN BINDING PROTEIN;

ADULT; AGED; ARTICLE; BLOOD FLOW; CARDIOVASCULAR SYSTEM; CHEMOLUMINESCENCE; ENDOTHELIUM; FEMALE; FLOW MEDIATED VASODILATATION; GLUCOSE BLOOD LEVEL; HEALTH; HUMAN; HYPERTENSION; IMMUNOASSAY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; RISK; SEX DIFFERENCE; ULTRASOUND; VASODILATATION; BLOOD; CROSS-SECTIONAL STUDY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; ENDOTHELIUM; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; SEX FACTORS; VASODILATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3;

EID: 77957145334     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0563     Document Type: Article

References (34)

1. Sara VR & Hall K. Insulin-like growth factors and their binding proteins. Physiological Reviews 1990 70 591-614. (Pubitemid 20196044)
2. Rinderknecht E & Humbel RE. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. Journal of Biological Chemistry 1978 253 2769-2776.
3. Mathews LS, Norstedt G & Palmiter RD. Regulation of insulin-like growth factor I gene expression by growth hormone. PNAS 1986 83 9343-9347. (doi:10.1073/pnas.83.24.9343)
4. Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 1997 29 691-699. (Pubitemid 27097972)
5. Chisalita SI & Arnqvist HJ. Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells. American Journal of Physiology. Endocrinology and Metabolism 2004 286 E896-E901. (doi:10.1152/ajpendo.00327.2003)
6. Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC & Goligorsky MS. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney International 1994 45 598-604. (doi:10.1038/ki.1994.78)
7. Walsh MF, Barazi M, Pete G, Muniyappa R, Dunbar JC & Sowers JR. Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology 1996 137 1798-1803. (doi:10.1210/en.137.5.1798)
8. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Hormone and IGF Research 2003 13 113-170. (doi:10.1016/S1096-6374(03)00038-8) (Pubitemid 36986557)
9. Deanfield JE, Halcox JP & Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007 115 1285-1295. (doi:10.1161/CIRCULATIONAHA.106.652859)
10. Martin RM, Gunnell D, Whitley E, Nicolaides A, Griffin M, Georgiou N, Davey Smith G, Ebrahim S & Holly JM. Associations of insulin-like growth factor (IGF)-I, IGFII, IGF binding protein (IGFBP)-2 and IGFBP-3 with ultrasound measures of atherosclerosis and plaque stability in an older adult population. Journal of Clinical Endocrinology and Metabolism 2008 93 1331-1338. (doi:10.1210/jc.2007-2295)
11. Juul A, Scheike T, Davidsen M, Gyllenborg J & Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002 106 939-944. (doi:10.1161/01.CIR.0000027563.44593.CC)
12. Johnsen SP, Hundborg HH, Sorensen HT, Orskov H, Tjonneland A, Overvad K & Jorgensen JO. Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. Journal of Clinical Endocrinology and Metabolism 2005 90 5937-5941. (doi:10.1210/jc.2004-2088)
13. Kaplan RC, McGinn AP, Pollak MN, Kuller LH, Strickler HD, Rohan TE, Cappola AR, Xue X & Psaty BM. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. Journal of Clinical Endocrinology and Metabolism 2007 92 1319-1325. (doi:10.1210/jc.2006-1631)
14. Laughlin GA, Barrett-Connor E, Criqui MH & Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. Journal of Clinical Endocrinology and Metabolism 2004 89 114-120. (doi:10.1210/jc.2003-030967)
15. Abdu TA, Elhadd TA, Buch H, Barton D, Neary R & Clayton RN. Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk. Clinical Endocrinology 2004 61 387-393. (doi:10.1111/j.1365-2265.2004.02109.x)
16. van der Klaauw AA, Pereira AM, Rabelink TJ, Corssmit EP, Zonneveld AJ, Pijl H, de Boer HC, Smit JW, Romijn JA & de Koning EJ. Recombinant human GH replacement increases CD34+ cells and improves endothelial function in adults with GH deficiency. European Journal of Endocrinology 2008 159 105-111. (doi:10.1530/EJE-08-0179)
17. Sakai H, Tsuchiya K, Nakayama C, Iwashima F, Izumiyama H, Doi M, Yoshimoto T, Tsujino M, Yamada S & Hirata Y. Improvement of endothelial dysfunction in acromegaly after transsphenoidal surgery. Endocrine Journal 2008 55 853-859. (doi:10.1507/endocrj.K07E-125)
18. Perticone F, Sciacqua A, Perticone M, Laino I, Miceli S, Care I, Galiano Leone G, Andreozzi F, Maio R & Sesti G. Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects. Journal of Clinical Endocrinology and Metabolism 2008 93 2806-2810. (doi:10.1210/jc.2008-0646)
19. Volzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, Aumann N, Lau K, Piontek M, Born G, Havemann C, Ittermann T, Schipf S, Haring R, Baumeister SE, Wallaschofski H, Nauck M, Frick S, Arnold A, Junger M, Mayerle J, Kraft M, Lerch MM, Dorr M, Reffelmann T, Empen K, Felix SB, Obst A, Koch B, Glaser S, Ewert R, Fietze I, Penzel T, Doren M, Rathmann W, Haerting J, Hannemann M, Ropcke J, Schminke U, Jurgens C, Tost F, Rettig R, Kors JA, Ungerer S, Hegenscheid K, Kuhn JP, Kuhn J, Hosten N, Puls R, Henke J, Gloger O, Teumer A, Homuth G, Volker U, Schwahn C, Holtfreter B, Polzer I, Kohlmann T, Grabe HJ, Rosskopf D, Kroemer HK, Kocher T, Biffar R, John U & Hoffmann W. Cohort profile: the Study of Health in Pomerania. International Journal of Epidemiology 2010 In Press. (doi:10.1093/ije/dyp394)
20. John U, Greiner B, Hensel E, Ludemann J, Piek M, Sauer S, Adam C, Born G, Alte D, Greiser E, Haertel U, Hense HW, Haerting J, Willich S & Kessler C. Study of Health in Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Sozial- und Präventivmedizin 2001 46 186-194. (doi:10.1007/BF01324255)
21. Cockcroft DW & Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16 31-41. (doi:10.1159/000180580)
22. Krebs A, Wallaschofski H, Spilcke-Liss E, Kohlmann T, Brabant G, Volzke H & Nauck M. Five commercially available insulin-like growth factor I (IGF-I) assays in comparison to the former Nichols Advantage IGF-I in a growth hormone treated population. Clinical Chemistry and Laboratory Medicine 2008 46 1776-1783. (doi:10.1515/CCLM.2008.349)
23. Volzke H, Robinson DM, Spielhagen T, Nauck M, Obst A, Ewert R, Wolff B, Wallaschofski H, Felix SB & Dorr M. Are serum thyrotropin levels within the reference range associated with endothelial function? European Heart Journal 2009 30 217-224. (doi:10.1093/eurheartj/ehn508)
24. Little RJ & Vartivarian S. On weighting the rates in non-response weights. Statistics in Medicine 2003 22 1589-1599. (doi:10.1002/sim.1513)
25. Landmesser U & Drexler H. Endothelial function and hypertension. Current Opinion in Cardiology 2007 22 316-320. (doi:10.1097/HCO. 0b013e3281ca710d)
26. Friedrich N, Haring R, Nauck M, Ludemann J, Rosskopf D, Spilcke- Liss E, Felix SB, Dorr M, Brabant G, Volzke H & Wallaschofski H. Mortality and serum insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Journal of Clinical Endocrinology and Metabolism 2009 94 1732-1739. (doi:10.1210/jc.2008-2138)
27. Andreassen M, Raymond I, Kistorp C, Hildebrandt P, Faber J & Kristensen LO. IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. European Journal of Endocrinology 2009 160 25-31(doi:10.1530/EJE-08-0452)
28. Page JH, Ma J, Pollak M, Manson JE & Hankinson SE. Plasma insulinlike growth factor 1 and binding-protein 3 and risk of myocardial infarction in women: a prospective study. Clinical Chemistry 2008 54 1682-1688. (doi:10.1373/clinchem.2008.105825)
29. Gatford KL, Egan AR, Clarke IJ & Owens PC. Sexual dimorphism of the somatotrophic axis. Journal of Endocrinology 1998 157 373-389. (doi:10.1677/joe.0.1570373)
30. Span JP, Pieters GF, Sweep FG, Hermus AR & Smals AG. Gender differences in rhGH-induced changes in body composition in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 2001 86 4161-4165. (doi:10.1210/jc.86.9.4161)
31. Burman P, Johansson AG, Siegbahn A, Vessby B & Karlsson FA. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. Journal of Clinical Endocrinology and Metabolism 1997 82 550-555. (doi:10.1210/jc.82.2.550) (Pubitemid 27068627)
32. Johansson AG. Gender difference in growth hormone response in adults. Journal of Endocrinological Investigation 1999 22 58-60.
33. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard- Herman M, Herrington D, Vallance P, Vita J & Vogel R. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. Journal of the American College of Cardiology 2002 39 257-265. (doi:10.1016/S0735-1097(01) 01746-6)
34. Guthikonda S, Sinkey CA & Haynes WG. What is the most appropriate methodology for detection of conduit artery endothelial dysfunction? Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 1172-1176. (doi:10.1161/ATVBAHA.106.131011)